Ivers-Read Gillian C

Avg. Two Year Performance

320% Avg. Purchase Return
105% Compound
41% Avg. Sale Return
19% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return6%81%42%(9%)320%
Purchase Success Rate1 of 11 of 11 of 10 of 11 of 1
Average Sale Return< 1%5%17%40%41%
Sale Success Rate18 of 3621 of 3619 of 3617 of 3615 of 36
Drugs » Biotechnology

See Remarks:

Holdings: 293.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--